We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$546M
AUM Growth
-$31.1M
Cap. Flow
+$46.9M
Cap. Flow %
8.6%
Top 10 Hldgs %
37.26%
Holding
117
New
22
Increased
53
Reduced
27
Closed
15

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$20.3M
2
HCA icon
HCA Healthcare
HCA
+$15.4M
3
COO icon
Cooper Companies
COO
+$9.29M
4
CRL icon
Charles River Laboratories
CRL
+$9.07M
5
ZBH icon
Zimmer Biomet
ZBH
+$9.02M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$14.6M
2
LNTH icon
Lantheus
LNTH
+$14.3M
3
WAT icon
Waters Corp
WAT
+$10.8M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$5.89M
5
SDGR icon
Schrodinger
SDGR
+$4.59M

Sector Composition

Rank Sector Weight
1 Healthcare 99.65%
2 Industrials 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYGR icon
101
Voyager Therapeutics
VYGR
$197M
$467K 0.09%
60,322
+2,441
+4% +$22.3K
TERN
102
DELISTED
Terns Pharmaceuticals
TERN
$210K 0.04%
41,728
-60,697
-59% -$385K
AXGN icon
103
Axogen
AXGN
$2.67B
– –
-260,858
Closed -$2.38M
CDTX
104
DELISTED
Cidara Therapeutics
CDTX
– –
-6,801
Closed -$154K
DHR icon
105
Danaher
DHR
$145B
– –
-68,465
Closed -$14.6M
IMVT icon
106
Immunovant
IMVT
$8.8B
– –
-216,868
Closed -$4.11M
KRMD icon
107
KORU Medical Systems
KRMD
$152M
– –
-899,063
Closed -$3.1M
MLYS icon
108
Mineralys Therapeutics
MLYS
$2.38B
– –
-11,658
Closed -$199K
MMS icon
109
Maximus
MMS
$2.85B
– –
-50,381
Closed -$4.26M
SAGE
110
DELISTED
Sage Therapeutics
SAGE
– –
-70,033
Closed -$3.29M
SVRA icon
111
Savara
SVRA
$1.17B
– –
-206,607
Closed -$660K
WAT icon
112
Waters Corp
WAT
$40.9B
– –
-40,688
Closed -$10.8M
GRTX
113
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
– –
-540,847
Closed -$1.69M
SWAV
114
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-10,076
Closed -$2.88M
MRNS
115
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-171,075
Closed -$1.86M
NSTG
116
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-187,500
Closed -$759K
SGEN
117
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-22,602
Closed -$4.35M
1 2 3 4
5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Parkman Healthcare Partners held 117 positions worth $546M, down 5.4% from $577M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parkman Healthcare Partners deployed $46.9M of net new capital in Q3 2023, opening 22 new positions and adding to 53 existing holdings. Its largest new stake was HCA Healthcare: 56,160 shares worth $13.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Lantheus, an estimated $14.3M trimmed.

  • Parkman Healthcare Partners's largest Q3 2023 buy was HCA Healthcare: 56,160 shares worth $13.8M.
  • Parkman Healthcare Partners added most to DexCom in Q3 2023, an estimated $20.3M increase.
  • Parkman Healthcare Partners's biggest Q3 2023 reduction was Lantheus, cutting an estimated $14.3M.
  • Parkman Healthcare Partners fully exited Danaher in Q3 2023, selling an estimated $14.6M.
  • Parkman Healthcare Partners's ten largest holdings make up 37% of its $546M portfolio in Q3 2023.
  • Parkman Healthcare Partners opened 22 new positions and closed 15 in Q3 2023.
  • Parkman Healthcare Partners's portfolio value fell 5.4% quarter-over-quarter to $546M.

Based on Parkman Healthcare Partners's 13F filing for Q3 2023, filed 14 Nov 2023.